| Social Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Investing > 2006 Was Huge For Uranium - 2007 Could Be Even Better! |
|
Social Articles - 2006 Was Huge For Uranium - 2007 Could Be Even Better!
As we enter a new year, we marvel at the mass media for once again missing the boat when it
comes to investment news stories for 2006.According to the mass media, the Dow breaking into a
new high was the story or the year. The Dow was up 14.7% last year which was an excellent year for the index. But According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product uranium was up almost 100% (97%) last year. We have had a number of readers ask us why we are not more heavily invested in the mainstream markets; our answer is that we prefer 100% gains to 14.7% gains. Amazing at it may seem, the fact that uranium has jumped up over 600% in 3 years, you would think ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in that the main stream investors and media would take notice. But to date, we have seen very little in the way of coverage of this amazing bull market. The fact that uranium has not had one pull back in this entire run, and there is virtually no media coverage tells us that we are still very early in th lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. s bull market. One of the aspects that we are very excited about is that the stocks have not kept up with the metal price. We are expecting some phenomenal jumps in share prices, maybe very soon, in order for the stocks to catch up to the metal. We have seen some of these stocks move lately, but ther here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe is more to come. Remember that the fundamentals for uranium are still very strong today. • There currently 445 Nuclear plants operating in the world today. There are 178 more pants under construction, planned or proposed. If all come on line, this would be a 40% increase. • Nuclear power plants mu d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro t have uranium in order to operate. Without uranium it is lights
out for these Nuclear Plants. • The cost of uranium in the overall cost of running the nuclear facility, is minimal compared to other fuel sources. As the cost of uranium increases, the impact on the cost of the nuclear plant is mini ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc mal. This is not the case with other forms of energy. • Uranium also has the advantage of being a highly concentrated source of energy which is easily and cheaply transportable. The quantities needed are very much less than for coal or oil. One kilogram of natural uranium will yield about 20,000 tim easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi s as much energy as the same amount of coal. It is therefore intrinsically a very portable and tradable commodity. • Morgan Stanley documented that “mining fails to keep pace with demand. Uranium mine production in 2003 satisfied only 53% of our estimated demand for uranium. The balance of demand was nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically met from stock depletion and dilution of weapons grade highly enriched uranium.” After the cigar lake flooding, there are no new large supplies of uranium scheduled to come into production until at least 2010. One possible setback is the announcement that the Department of Energy planned to sell off and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ome of its decommissioned nuclear weapons uranium. Although this suggests that prices could drop, when the announcement was made, the price of uranium went up, not down. Should we get a correction in the uranium prices, which we feel is unlikely, then this would be another excellent buying opportunity ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi We want to make it very clear to our subscribers, that we are still very bullish of uranium. Until we see the mass media and then the mass investors start to take notice, we will remain bullish. Uranium is still page 16 news, if it gets any at all. Until it works its way to page 1, we are riding this ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a bull market out. Remember our keys to success are maximizing profits and minimizing losses. For those who have not yet jumped on this band wagon we do not believe that it is too late to make good profits. The fundamentals are still very strong. And until we see this bull market start to get the cove dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod age that it will get, it is still early in this bull market. Although uranium is far from page 1 news, it is getting some coverage in the media. In a Bloomberg article we see that Merrill Lynch has raised its 2008 uranium price forecast by 78%, due to the Cigar Lake disaster and new demand coming for cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin China and India. “ In their December 8th report, they are now predicting the average price in 2007 to be $75 a pound and $80 in 2008. Merrill Lynch notes that this year uranium had averaged $46 a pound, so their new view is rather impressive for uranium stock holders. “We do not see a major trigger o tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen the horizon that will force spot prices down” says the Merrill Lynch analyst. “ “The delay of Cigar Lake and the immanent arrival of India into the commercial fuel market have created a notable increase in demand.” At the end of November, 28 plants were under construction with a further 62 ordered o t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel planned. India, which runs 16 reactors, is building another 7. Merrill Lynch had expected 2008 prices to decline after averaging $53 in 2007.” In another article we see that Scotiabank Vice President, Industry and Commodity Market Research, Patricia Mohr has forecast uranium and zinc as her top pick ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust s for investors in 2007, with precious metals, particularly silver, expected to benefit from further weakness in the U.S. dollar. In her recently published analysis, Mohr said “uranium was the third-best performing commodity this year “and will likely be the top performer in 2007.” She forecast that s y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ot uranium prices are expected to average US$80 a pound in 2008, possibly ending 2007 close to $90. “The current upswing in uranium prices represents a ‘secular’ transformational change in global energy markets related partly to a shift by utilities from high-priced fossil fuels-rather than a ‘cyclic . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de l’ upswing,” Mohr asserted. “Nuclear energy is used for ‘base load’ electricity generation
and will be little affected by an expected modest slowdown in global growth in 2007 (4.7% down from 5.2% in 2006), using ‘purchasing power parity’ estimates.” This uranium bull market will come to an end and t elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e profits will be tougher to get, but for now we are still very bullish on this market. Things could start moving much quicker as we move forward so we are looking to a great year for uranium in 2007. To subscribe go to www.thetrendletter.com tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Employment Interviewing: Ask For The Job What is So Exciting about Money and the Internet? Lead Generation #7 - Why Repeat Buyers Will Create Profits On-Line
|